Landscapes / Companies

InnoCare Pharma Inc. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved in China
Next date
Mesutoclax, Phase 1 trial completes
Drugs
2
in active trials · 4 in all
Trials
2 active
5 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
Bruton's tyrosine kinase inhibitor
Beijing InnoCare Pharma Tech
Approved in China 25 Jun 2031Phase 3 trial completes
Mesutoclaxnot checked
—
Beijing InnoCare Pharma Tech
Phase 1 25 Jun 2027Phase 1 trial completes

About

No active trial
ICP-332, ICP-723
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021

Follow InnoCare Pharma Inc.

Following is part of Solo: you see every change to InnoCare Pharma Inc. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in